Search Results for "Top 10 Neuroscience Projects To Watch 2013 14"

02:24 EDT 2nd October 2014 | BioPortfolio

Matching Channels

Mesenchymal Epithelial Transition factor c MET

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF...

AstraZeneca

AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and em...

Staphylococcal aureus infections

Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

Merck and Co

Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the ...

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in ...

Matching News

J&J, U of Toronto in neuroscience deal

The Janssen Biotech Inc. subsidiary of Johnson & Johnson (NYSE:JNJ) partnered with the University of Toronto's Center for Collaborative Drug Research (CCDR) to develop therapies to treat mood disorder...

AT&T Among First To Offer LG G Watch

DALLAS, June 25, 2014 /PRNewswire/ --AT&T today announced it will be among the first U.S. carriers to bring the LG G Watch to its portfolio of accessories. "The LG G Watch is a great addition to A...

The Apple Watch and Health

Apple recently unveiled its smart watch.  The watch not only is a mini-computer, but it can help improve your health. Pharmafile reports: The watch comes with an app that promises to calculate all ki...

There’s no longer anything novel about fitness watches — but at least Withings’ looks good

Withings describes its new Activité watch like this: “The first Swiss made watch that happens to be an activity tracker.” And that’s the coolest thing about this watch. There’s no...

20 Promising Drugs to Watch in 2014

Peter Robins writes for Outsourced Pharma on promising drugs changing clinical phase or receiving approval. Numerous drug therapies changed clinical phase, received approval, and launched in the final...

Fattah Statement on NSF Awarding $10.8 Million in EAGER Grants for Neuroscience Research

WASHINGTON, Aug. 19, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), lead Democrat appropriator for National Science Foundation (NSF) funding and creator of the Fattah Neuroscience In...

Fattah Statement on White House BRAIN Initiative Announcement

WASHINGTON, Sept. 30 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), a Senior Member on the House Appropriations Committee and architect of the Fattah Neuroscience Initiative, is...

Neurobiologist Thomas Jessell to be honored with 2014 Gruber Neuroscience Prize

Thomas Jessell, PhD, the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is the recipient of the ...

Matching PubMed Articles

Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live?

Rretraction notice to ‘‘1h-MRS can monitor metabolites changes of lateral intraventricular BDNF infusion into a mouse model of Alzheimer’s disease in vivo’’ Neuroscience 245 (2013) 40–49.

Retraction notice to ‘‘The effect of maternal infection on cognitive development and hippocampus neuronal apoptosis, proliferation and differentiation in the neonatal rats’’ Neuroscience 246 (2013) 422–434.

Discontinued in 2013: diabetic drugs.

Introduction: The increasing prevalence of diabetes, with no cure on the horizon, continues to provide biopharmaceutical companies with an incentive to develop novel therapies and improve existing com...

Cephalopods in neuroscience: regulations, research and the 3Rs.

Cephalopods have been utilised in neuroscience research for more than 100 years particularly because of their phenotypic plasticity, complex and centralised nervous system, tractability for studies o...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement